- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/49 - Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
Patent holdings for IPC class C07D 239/49
Total number of patents in this class: 114
10-year publication summary
|
19
|
14
|
15
|
5
|
14
|
8
|
3
|
3
|
5
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sumitomo Pharma Co., Ltd. | 555 |
16 |
| Apros Therapeutics, Inc. | 10 |
7 |
| AstraZeneca AB | 2814 |
5 |
| Board of Regents, The University of Texas System | 6107 |
5 |
| Dainippon Sumitomo Pharma Co., Ltd. | 167 |
5 |
| AstraZeneca UK Limited | 528 |
4 |
| The Trustees of the University of Pennsylvania | 4415 |
4 |
| Calitor Sciences, LLC | 37 |
3 |
| Plexxikon Inc. | 146 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 626 |
3 |
| Tokyo University of Science Foundation | 435 |
3 |
| Acea Therapeutics, Inc. | 31 |
3 |
| Bristol-myers Squibb Company | 4742 |
2 |
| FUJIFILM Corporation | 30514 |
2 |
| Massachusetts Institute of Technology | 10251 |
2 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1021 |
2 |
| Minoryx Therapeutics S.L. | 44 |
2 |
| Oat Agrio Co., Ltd. | 43 |
2 |
| Roche Palo Alto LLC | 64 |
2 |
| Sumitomo Dainippon Pharma Co., Ltd. | 211 |
2 |
| Other owners | 37 |